Xingye Stock has released an announcement to caution investors about the inherent risks in stock trading. The announcement clarifies that the phenolic resin intended for use in semiconductor photoresist is presently at the sample testing stage, with no supply contracts having been signed to date. Consequently, this development has not influenced the company's financial performance. Furthermore, the company notes that the sales volume of the impregnated resin employed in the brakes of the domestically manufactured C919 large aircraft remains relatively modest. Xingye Stock urges investors to be mindful of the associated business risks.